BioCentury
ARTICLE | Top Story

EMIS Phase III finish slated for 2002

May 1, 2001 7:00 AM UTC

Emisphere (EMIS) said it expects to complete in the second quarter of 2002 a Phase III trial comparing its oral heparin with Lovenox enoxaparin low molecular weight heparin from Aventis (AVE) in preve...